Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 3, 2005, Pages 437-463

  Gottschalk, Paul G ^a   Dunn, John R ^a  

^a Brendan Technologies Inc   (United States)

Author keywords

Bioassay; Five parameter logistic; Four parameter logistic; Immunoassay; Linearity; Nonlinear weighted regression; Parallelism; Relative potency

Indexed keywords

ARTICLE; BIOASSAY; CHI SQUARE TEST; CURVE FITTING; DOSE RESPONSE; IMMUNOASSAY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ALGORITHMS; BIOLOGICAL ASSAY; DATA INTERPRETATION, STATISTICAL; IMMUNOASSAY; MODELS, STATISTICAL; PROBABILITY; REPRODUCIBILITY OF RESULTS;

EID: 18744391651     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-200056532     Document Type: Article

References (36)

1. Bates, D. M., Watts, D. G. (1988a). Comparing models. In: Nonlinear Regression Analysis and Its Applications. New York: Wiley, pp. 103-108.
2. Bates, D. M., Watts, D. G. (1988b). Graphical summaries of nonlinear inference regions. In: Nonlinear Regression Analysis and Its Applications. New York: Wiley, pp. 201-231.
3. Bates, D. M., Watts, D. G. (1988c). Curvature measures of nonlinearity. In: Nonlinear Regression Analysis and Its Applications. New York: Wiley, pp. 232-263.
4. Brendan Technologies, Inc. (2004). StatLIA 3.2 Reference Manual. Carlsbad, California: Brendan Technologies, Inc. www.brendan.com.
5. Callahan, J. D., Sajjadi, N. C. (2003). Testing the null hypothesis for a specified difference - The right way to test for parallelism. BioProcess. J. 2:1-6.
6. Das, R. E. G. (2002). Statistical considerations in the design and analysis of parallel line assays. In: Brown, F., Mire-Sluis, A., eds. Design and Analysis of Potency Assays for Biotechnology Products. Dev. Biol. 107:35-46.
7. Davenport, W. B. (1970). Probability and Random Processes. New York: McGraw-Hill, p. 252.
8. Davies, C. (1994). Principles. In: Wild, D., ed. The Immunoassay Handbook. New York: Stockton, pp. 3-44.
9. De Lean, A. P., Munson, P. J., Rodbard, D. (1978). Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235(E):97-102.
10. Design and Analysis of Biological Assays, General Chapter. (2000). In: United States Pharmacopoeia 24 National Formulary 19. The United States Pharmacopoeial Convention, Rockville, MD.
11. Draper, N. R., Smith, H. (1998a). Extra sum of squares and tests for several parameters being zero. Applied Regression Analysis. 3rd ed. New York: Wiley, pp. 149-165.
12. Draper, N. R., Smith, H. (1998b). An introduction to nonlinear estimation. Applied Regression Analysis 3rd ed. New York: Wiley, pp. 505-553.
13. Dudley, R. A., Edwards, P., Ekins, R. P., Finney, D. J., McKenzie, I. G. M., Raab, G. M., Rodbard, D., Rodgers, R. P. C. (1985). Guidelines for immunoassay data processing. Clin. Chem. 31(8):1264-1271.
14. Finney, D. J. (1978). Parallel line assays. In: Statistical Methods in Biological Assays. 3rd ed. London: Charles Griffin, pp. 69-132.
15. Finney, D. J., Schild, H. O. (1966). Parallel line assay with successive adjustment of doses. Br. J. Pharm. Chemother. 28:84-92.
16. Finney, D. J., Phillips, P. (1977). The form and estimation of a variance function, with particular reference to immunoassay. Appl. Stat. 26:312-320.
17. Giltinian D. (2002). Selected topics in parallel line bioassay in design and analysis of potency assays for biotechnology products. Dev. Biol. 107:47-56.
18. Gottschalk, P. G., Dunn, J. R. (in press a). The five parameter logistic: A characterization and comparison with the four parameter logistic.
19. Gottschalk, P. G., Dunn, J. R. (in press b). Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
20. Guardbasso, V., Rodbard, D., Munson, P. J. (1987). A model-free approach to estimation of relative potency in dose-response curve analysis. Am. J. Physiol. E 252:357-364.
21. Hogg, R. V., Tanis, E. A. (1977). Probability and Statistical Inference. 5th ed. Upper Saddle River, New Jersey: Prentice Hall.
22. Klein, J., Capen, R., Mancinelli, R., Robinett, R., Pietrobon, P., Quinn, J., Schofield, T. (1999). Validation of assays for use with combination vaccines. Biologicals 27:35-41.
23. Kroll, M. H., Praestgaard, J., Michaliszyn, E., Styer, P. E. (2000). Evaluation of the extent of nonlinearity in reportable range studies. Arch. Pathol. Labor. Med. 124(9):1331-1338.
24. Krouwer, J. S., Schlain, B. (1993). A method to quantify deviations from assay linearity. Clin. Chem. 39:1689-1693.
25. Lansky, D. (2003). Confidence intervals, not tests for assessing parallelism. In: IBC Biological Assay Development and Validation Conference Bethesda Maryland, May 6.
26. Plikaytis, B. D., Holder, P. F., Pais, L. B., Maslanka, S. E., Gheesling, L. L., Carlone, G. M. (1994). Determination of parallelism and nonparallelism in bioassay dilution curves. J. Clin. Microbiol. 32(10):2441-2447.
27. Prentice, R. L. A. (1976). A generalization of the probit and logit methods for dose response curves. Biometrics 32:761-768.
28. Raab, G. M. (1981). Estimation of a variance function, with application to immunoassay. Appl. Stat. 3(1):32-40.
29. Raab, G. M. (1983). Comparison of a logistic and a mass action curve for radioimmunoassay data. Clin. Chem. 29(10):1757-1761.
30. Reeve, R. (2000). Two statistical methods for estimating relative potency of bioassays. BioPharm. 13(7):54-60.
31. Rodbard, D., Hutt, D. M. (1974). Statistical analysis of radioimmunoassays and immunoradiometric (labeled antibody) assays: A generalized weighted, iterative, least-squares method for logistic curve fitting. In: Radioimmunoassay and Related Procedures in Medicine 1. Vienna, Italy: Int. Atomic Energy Agency, pp. 165-192.
32. Rodbard, D., Munson, P. J., DeLean, A. (1978). Improved curve fitting, parallelism testing, characterization of sensitivity and specificity, validation, and optimization for radioimmunoassays. In: Radioimmunoassay and Related Procedures in Medicine 1. Vienna, Italy, 1977: Int. Atomic Energy Agency, pp. 469-504.
33. Rodbard, D., Rayford, P. L., Cooper, J. A., Ross, G. T. (1968). Statistical quality control of radioimmunoassays. J. Clin. Endocrinol. 28:1412.
34. Smith, W. C., Sittampalam, G. S. (1998). Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications. J. Biopharm. Stat. 8(4):509-532.
35. Statistical Analysis of Results of Biological Assays and Results. (2003). European Pharmacopoeia. 4th ed. Supplement 4.7, pp. 4282-4283.
36. Tholen, D. W. (1992). Alternative statistical techniques to evaluate linearity. Arch. Pathol. Labor. Med. 116(7):746-756.